Medical Devices: Page 137
-
Canon gets FDA nod for AI tech to enhance CT images
Rising use of CT scans, which expose patients to far more radiation than X-rays, has intensified focus on the risks of the imaging technique, particularly in the pediatric population.
By Nick Paul Taylor • Oct. 22, 2019 -
Sleep apnea testing shifts to the home, survey suggests
Use of home-based testing has more than doubled in the past five years as more sleep centers offer the option, which analysts expect will benefit ResMed.
By Susan Kelly • Oct. 21, 2019 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineMedical device safety in spotlight after high profile recalls
From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.
By MedTech Dive staff -
Smith & Nephew taps new CEO with diagnostics, orthopaedics resume
Namal Nawana led the medtech for just 18 months, but reportedly clashed with the board over pay. Smith & Nephew's stock was down nearly 10% Monday.
By Dana Elfin • Oct. 21, 2019 -
TAVR vet in at Medtronic diabetes unit amid shakeup
Cardiac and Vascular Group veteran Sean Salmon will step in to lead Medtronic Diabetes, which has faced an uptick in market competition from CGM makers Abbott and Dexcom and insulin pump manufacturers Tandem and Insulet.
By Maria Rachal • Oct. 21, 2019 -
Doctor hit with guilty verdict for reusing contaminated catheters, defrauding Medicare
A California physician submitted approximately $12 million worth of claims to Medicare for the medically unnecessary procedures, pocketing $4.5 million.
By Dana Elfin • Oct. 18, 2019 -
Leasing da Vinci systems is in style: Intuitive Q3 tops estimates
The results come as potential competitors Transenterix and Titan Medical stumbled in the past week and Medtronic inches forward with its own robotic surgery platform.
By Maria Rachal • Oct. 18, 2019 -
Sens. Warren, Cassidy press FDA on difference between servicing and remanufacturing
The agency does not require servicers, who face fewer regulatory requirements than remanufacturers, to register with FDA.
By David Lim • Oct. 18, 2019 -
AdvaMed lobbies Trump to repeal medical device tax (again)
The trade organization has successfully delayed the levy for years, but the latest moratorium expires at year's end.
By Nick Paul Taylor • Oct. 18, 2019 -
TransEnterix seeks 'strategic alternatives' amid robot slump, restructuring
RBC analysts said a sale of the company is the most likely outcome after the medtech engaged J.P. Morgan to explore its options. The company's CFO will depart at the end of the year.
By Nick Paul Taylor • Oct. 18, 2019 -
Researchers question safety benefit of robotic colectomies
Despite a sharp rise in robot-assisted colon removal procedures using devices like Intuitive Surgical's da Vinci system, research published in JAMA Surgery found a laparoscopic approach has a comparable rate of complications.
By Nick Paul Taylor • Oct. 17, 2019 -
Key committee pitches adding UDIs to payer claim forms, called 'huge step'
If a unique device identifier is captured when a high-risk product is implanted, providers will be able to detect complications more quickly, Joe Drozda, the director of outcomes research at Mercy Health, told MedTech Dive.
By David Lim • Oct. 17, 2019 -
FDA grants breakthrough status to next-generation PSA test
Cleveland Diagnostics' test aims to reduce the number of patients undergoing unnecessary biopsies by looking at structural changes to the protein tied to cancer mutations.
By Nick Paul Taylor • Oct. 17, 2019 -
Abbott 'working through a handful of items' with FDA on FreeStyle Libre 2
Third-quarter revenue for the medtech came in at $8.08 billion, slightly below Wall Street expectations, but executives praised the growth of key products FreeStyle Libre, MitraClip and Alinity on its earnings call.
By David Lim • Oct. 16, 2019 -
FDA warns dental X-ray supplier over radiation exposure reporting
The agency said Denterprise International didn't report complaints involving patients accidentally exposed to radiation and asked for a retrospective review of all such incidents.
By Susan Kelly • Oct. 16, 2019 -
CMR launches robot, CEO says European deals coming soon
On the back of a $240 million private financing round, the U.K. medtech is beginning commercial expansion of its modular robotic surgery system in Europe and Asia as it awaits FDA's go-ahead.
By Maria Rachal • Oct. 16, 2019 -
ViewRay bucks payment fears in field dubbed 'not dead' yet
The radiation oncology company received eight new orders for its MRI-guided Linac, easily beating Jefferies' forecast.
By Nick Paul Taylor • Oct. 16, 2019 -
Titan scraps filing plan for robotic surgical system amid cash crunch
The Canadian medtech is abandoning plans to seek FDA clearance to sell its single port system before 2021.
By Nick Paul Taylor • Oct. 16, 2019 -
J&J device business outperforms in China as US pricing pressures persist
Double-digit sales growth in China and a surge in contact lens purchases in Japan helped offset share declines in certain U.S. orthopaedics markets.
By Maria Rachal • Oct. 15, 2019 -
California bill to end excessive dialysis profits becomes law
Fresenius said it's concerned the new law will result in patients only being able to access care at hospitals due to lack of insurance coverage.
By Susan Kelly • Oct. 15, 2019 -
Two weeks from Brexit deadline, UK floats device contingency
A no-deal Brexit would not meet any of MedTech Europe's four priorities.
By Nick Paul Taylor • Oct. 15, 2019 -
Hospitals, manufacturers could donate cybersecurity software under proposed regs
With the cost of protecting systems from malicious hackers increasing, the idea to tweak the anti-kickback laws recognizes some physician practices don't have the resources or expertise to keep pace, one lawyer told MedTech Dive.
By David Lim • Oct. 14, 2019 -
Medical software makers get new guidance on MDR, IVDR
The European Commission's Medical Device Coordination Group aims to clarify which software will be subject to the new regulations, and how those products should be classified and placed on the market.
By Dana Elfin • Oct. 14, 2019 -
Abbott deepens Type 2 diabetes play with Omada partnership
While CGMs have been most widely adopted among the Type 1 population, Abbott has worked to show the technology's benefit in the under-penetrated Type 2 market, which accounts for 95% of all Americans living with diabetes.
By Maria Rachal • Oct. 14, 2019 -
FDA pushes back against criticism of third party 510(k) review
The agency deflected suggestions that the plan puts the burden on patients and doctors to figure out which devices are safe.
By Susan Kelly • Oct. 14, 2019 -
GAO finds low uptake of disposable wound care devices
Advocates of the products, sold by companies including Acelity and Smith & Nephew, argue the size and cost make them preferable to durable devices when treating small wounds.
By Nick Paul Taylor • Oct. 11, 2019
Previous
